Table_2_Immunogenomic Profiling Demonstrate AC003092.1 as an Immune-Related eRNA in Glioblastoma Multiforme.DOCX
Enhancer RNAs, a type of long non-coding RNAs (lncRNAs), play a critical role in the occurrence and development of glioma. RNA-seq data from 161 glioblastoma multiforme (GBM) samples were acquired from The Cancer Genome Atlas database. Then, 70 eRNAs were identified as prognosis-related genes, which had significant relations with overall survival (log-rank test, p < 0.05). AC003092.1 was demonstrated as an immune-related eRNA by functional enrichment analysis. We divided samples into two groups based on AC003092.1 expression: AC003092.1 High (AC003092.1_H) and AC003092.1 Low (AC003092.1_L) and systematically analyzed the influence of AC003092.1 on the immune microenvironment by single-sample gene-set enrichment analysis and CIBERSORTx. We quantified AC003092.1 and TFPI2 levels in 11 high-grade gliomas, 5 low-grade gliomas, and 7 GBM cell lines. Our study indicates that AC003092.1 is related to glioma-immunosuppressive microenvironment, and these results offer innovative sights into GBM immune therapy.
History
References
- https://doi.org//10.1038/75556
- https://doi.org//10.1038/nature08460
- https://doi.org//10.1093/nar/gkaa277
- https://doi.org//10.1101/gr.164079.113
- https://doi.org//10.1158/0008-5472.CAN-08-1961
- https://doi.org//10.1038/nrn3765
- https://doi.org//10.1038/nprot.2009.97
- https://doi.org//10.1093/nar/gku1179
- https://doi.org//10.1186/1471-2105-14-7
- https://doi.org//10.1073/pnas.1324151111
- https://doi.org//10.1038/s41590-018-0207-y
- https://doi.org//10.1161/01.atv.18.1.40
- https://doi.org//10.1038/ncomms4979
- https://doi.org//10.1016/j.cell.2018.03.064
- https://doi.org//10.1186/s12866-016-0750-3
- https://doi.org//10.1016/j.lungcan.2017.06.006
- https://doi.org//10.1186/1753-6561-3-s7-s94
- https://doi.org//10.1038/nrg.2016.4
- https://doi.org//10.1186/s12885-019-6032-3
- https://doi.org//10.1016/j.cell.2016.09.018
- https://doi.org//10.1093/nar/gkz646
- https://doi.org//10.18632/aging.102018
- https://doi.org//10.1038/nature21034
- https://doi.org//10.1038/s41587-019-0114-2
- https://doi.org//10.1016/j.ejphar.2010.12.015
- https://doi.org//10.1371/journal.pone.0052772
- https://doi.org//10.1186/s12943-018-0812-2
- https://doi.org//10.1038/nrm.2017.104
- https://doi.org//10.1038/cr.2017.35
- https://doi.org//10.1016/j.immuni.2015.05.004
- https://doi.org//10.1055/s-2007-991532
- https://doi.org//10.1186/1471-2164-10-22
- https://doi.org//10.1038/onc.2011.621
- https://doi.org//10.4161/15384101.2014.977641
- https://doi.org//10.1007/s11060-017-2667-6
- https://doi.org//10.1016/j.tcb.2011.04.001
- https://doi.org//10.1038/nrdp.2015.17
- https://doi.org//10.1038/s41419-018-1183-8
- https://doi.org//10.1038/ncomms3612
- https://doi.org//10.1038/s41467-019-12543-5
- https://doi.org//10.1007/s12035-017-0572-9
- https://doi.org//10.1038/s41467-019-09234-6
Usage metrics
Read the peer-reviewed publication
Categories
- Gene and Molecular Therapy
- Biomarkers
- Genetics
- Genetically Modified Animals
- Developmental Genetics (incl. Sex Determination)
- Epigenetics (incl. Genome Methylation and Epigenomics)
- Gene Expression (incl. Microarray and other genome-wide approaches)
- Livestock Cloning
- Genome Structure and Regulation
- Genetic Engineering
- Genomics
CC BY 4.0